Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

Clinical trial NCT04732949 · COMPLETED

Trial details

NCT number: NCT04732949
Sponsor: Synairgen Research Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus 2 COVID-19

Start date: 2021-01-12
Primary completion: 2021-12-15
Enrollment: 623

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.